期刊文献+

三参通痹冠心方联合西药治疗冠心病心绞痛40例

下载PDF
导出
摘要 目的:观察三参通痹冠心方联合西药治疗冠心病心绞痛的临床疗效。方法:选择河南中医药大学第三附属医院心血管内科住院部收治的冠心病心绞痛患者80例,按1∶1的比例随机分为两组。对照组给予西药治疗,治疗组在对照组治疗基础上给予三参通痹冠心方(丹参、红参、玄参、甘松、三七、红花、薤白、桂枝、全瓜蒌、当归、延胡索、黄芪、制附子、炙甘草),1 d 1剂,早晚各1次。两组均以2周为1个疗程,治疗1个疗程后判定疗效。结果:治疗组显效29例,有效9例,无效2例,有效率为95.0%;对照组显效19例,有效14例,无效7例,有效率为82.5%;两组对比,差异有统计学意义(P<0.05)。结论:三参通痹冠心方联合西药治疗冠心病心绞痛疗效确切。
出处 《中医研究》 2020年第10期26-28,共3页 Traditional Chinese Medicinal Research
  • 相关文献

参考文献1

二级参考文献11

  • 1Shah PK.Mechanisms of plaque vulnerability and rupture[J].J Am Coll Cardiol,2003,41(4 Suppl S):15S-22S.
  • 2Ross R.Atherosclerosis-an inflammatory disease[J].N Engl J Med,1999,340:115-126.
  • 3Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
  • 4Wilson AM,Ryan MC,Boyle AJ.Tbe novel role of C-reactive protein in cardiovascular disease:risk marker or pathologen[J].Int J Cardiol,2006,106(3):291-297.
  • 5Burker AP,Tracy BP,Kolodgie F,et al.Elevated C-reactive protein values and atherosclerosis in sudden coronary death:association with different pathologies[J].Circulation,2002,105:2019-2023.
  • 6Heeschen C,Dimmeler S,Hamm CW,et al.Soluble CD40 ligand in acute coronary syndromes[J].N Engl J Med,2003,348:1104-1111.
  • 7Varo N,Libby P,de Lemos JA,et al.Soluble CD40L risk prediction after acute coronary syndromes[J].Circulation,2003,108(9):1049-1052.
  • 8Cipollone F,Ferri C,Desideri G,et al.Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty[J].Circulation,2003,108(22):2776-2782.
  • 9Kai H,Ikeda H,Yasukawa H,et al.Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32(2):368-372.
  • 10Nomoto K,Oguchi S,Watanabe I,et al.Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein,matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1[J].J Cardiol,2003,42(5):201-206.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部